CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C. [electronic resource]
Producer: 20060921Description: 4721-6 p. digitalISSN:- 1007-9327
- Adult
- Alanine Transaminase -- blood
- Alleles
- Antiviral Agents -- therapeutic use
- Case-Control Studies
- Disease Progression
- Drug Therapy, Combination
- Female
- Genetic Predisposition to Disease
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- blood
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Male
- Middle Aged
- Mutation -- genetics
- Polyethylene Glycols
- Receptors, CCR5 -- genetics
- Recombinant Proteins
- Ribavirin -- therapeutic use
- Severity of Illness Index
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.